Portfolio (Quarterly)
Guide ↗
RHUMBLINE ADVISERS
· CIK 0001115418| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 4181 | — | STING ANTAGONIST CVR | — | 320.0 | — | — | NEW | — | — | — |
| 4182 | — | SUPERNUS PHARMA CVR | — | 87,512.0 | — | — | NEW | — | — | — |
| 4183 | — | TETRAPHASE PHARMACEUTICALS CVR | — | 98.0 | — | — | NEW | — | — | — |
| 4184 | — | XERIS BIOPHARMA NON-TRADEABLE CVR | — | 1,337.0 | — | — | NEW | — | — | — |
| 4185 | — | XOMA CORP CVR | — | 2,933.0 | — | — | NEW | — | — | — |
| 4186 | — | XYLOPHONE ACQUISITION CORP CVR | — | 805.0 | — | — | NEW | — | — | — |
| 4187 | — | ZAGG CVR - EXP 12-31-2022 | — | 1,044.0 | — | — | NEW | — | — | — |
| 4188 | — | ZIMMER BIOMET HLDS CVR | — | 67,326.0 | — | — | NEW | — | — | — |
| 4189 | SPRC | SCISPARC LTD | Healthcare | — | — | — | NEW | — | — | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
36.0%
Financial Services
11.1%
Industrials
10.0%
Consumer Cyclical
9.6%
Healthcare
9.3%
Communication Services
9.1%
Consumer Defensive
4.4%
Energy
3.3%
Utilities
2.7%
Real Estate
2.6%